Wesley Jackson

Wesley Jackson is a Sr. Principal Biophysical Chemist at Eli Lilly and Company, where they have held various roles since 2020, focusing on the study of aggregate formation in pharmaceutical formulations using advanced techniques such as HPLC-Multi Angle Light Scattering and Analytical Ultracentrifugation. Prior to this, Wesley worked as a Staff Scientist at NOAA/JHT and held positions at Lancaster Laboratories, where they contributed to GLP testing and developed methods for detecting genotoxic impurities. Wesley earned a Master's degree in Biochemistry from the Medical University of South Carolina and a Master's in Biological Sciences from Wright State University, along with a BA in Microbiology and Zoology from Miami University.